FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称CAFICRESTAT
异名/同义词(8-OXO-7-((5-(TRIFLUOROMETHYL)-1,3-BENZOTHIAZOL-2-YL)METHYL)-7,8-DIHYDROPYRAZINO(2,3-D)PYRIDAZIN-5-YL)ACETIC ACID
2-(8-OXO-7-((5-(TRIFLUOROMETHYL)BENZO(D)THIAZOL-2-YL)METHYL)-7,8-DIHYDROPYRAZINO(2,3-D)PYRIDAZIN-5-YL) ACETIC ACID
7,8-DIHYDRO-8-OXO-7-((5-(TRIFLUOROMETHYL)-2-BENZOTHIAZOLYL)METHYL)PYRAZINO(2,3-D)PYRIDAZINE-5-ACETIC ACID
ALDOSE REDUCTASE-IN-1
AT 001 [WHO-DD]
AT001
AT-001
CAFICRESTAT
CAFICRESTAT [INN]
CAFICRESTAT [USAN]
PYRAZINO(2,3-D)PYRIDAZINE-5-ACETIC ACID, 7,8-DIHYDRO-8-OXO-7-((5-(TRIFLUOROMETHYL)-2-BENZOTHIAZOLYL)METHYL)-
CAS登记号1355612-71-3
物质唯一标识(Unique Ingredient Identifier)E8I3O45DDU
分子式C17H10F3N5O3S
国际化合物标识(International Chemical Identifier,InChI)YRGPAXAVTDMKDK-UHFFFAOYSA-N
SMILESc1cnc2c(n1)c(n(nc2CC(O)=O)Cc3nc4c(s3)ccc(c4)C(F)(F)F)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System